期刊文献+

Estrogen and its signaling pathway in non-small cell lung cancer(NSCLC)

Estrogen and its signaling pathway in non-small cell lung cancer(NSCLC)
下载PDF
导出
摘要 Lung cancer is the most common cancer in the world. It is a highly lethal disease in women and men, and new treatments are urgently needed. Several studies have implicated a role of estrogens and estrogen receptors in lung cancer progression. This review will investigate the biological significance of estrogens in lung cancer cells, the expression and molecular mechanisms of estrogen receptors(ER α and ER β, elucidate the prognostic significance of estrogens and their receptors in lung carcinomas and provide new options for patients afflicted with lung malignancies. Lung cancer is the most common cancer in the world. It is a highly lethal disease in women and men, and new treatments are urgently needed. Several studies have implicated a role of estrogens and estrogen receptors in lung cancer progression. This review will investigate the biological significance of estrogens in lung cancer cells, the expression and molecular mechanisms of estrogen receptors(ER α and ER β, elucidate the prognostic significance of estrogens and their receptors in lung carcinomas and provide new options for patients afflicted with lung malignancies.
机构地区 Department of Oncology
出处 《Journal of Nanjing Medical University》 2009年第4期217-223,共7页 南京医科大学学报(英文版)
关键词 lung cancer ESTROGEN estrogen receptor EGFR lung cancer, estrogen, estrogen receptor, EGFR
  • 相关文献

参考文献11

  • 1Angela Brodie,Brian Long,Qing Lu.Aromatase expression in the human breast[J].Breast Cancer Research and Treatment.1998(1)
  • 2Likhite VS,Stossi F,Kim K,Katzenellenbogen BS.Kinasespecific phosphorylation of the estrogen receptor changes recep- tor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity[].Molecular Endocrinology.2006
  • 3Marquez-Garban DC,Chen HW,Fishbein MC,Goodglick L,Pietras RJ.Estrogen receptor signaling pathways in human non-small cell lung cancer[].Steroids.2007
  • 4Zhang G,Liu X,Farkas AM,Parwani AV,Lathrop KL,Lenzner D, et al.Estrogen receptor β functions through nongenomic mechanisms in lung cancer cells[].Molecular Endocrinology.2009
  • 5Traynor AM,Schiller JH,Stabile LP,Kolesar JM,Belani CP, et al.Combination therapy with gefitinib and fulvestrant (G/F) for women with non-small cell lung cancer(NSCLC)[].Lung Cancer.2005
  • 6Traynor AM,Schiller JH,Stabile LP,Kolesar JM,Eickhoff JC,Dacic S, et al.Pilot study of gefitinib and fulvestrant in thetreatment of post-menopausal women with advanced non-small cell lung cancer[].Lung Cancer.2008
  • 7Weinberg OK,Marquez-Garban DC,Fishbein MC,Goodglick L,Garban HJ,Dubinett SM, et al.Aromatase inhibitors in human lung cancer therapy[].Cancer Research.2005
  • 8Mah V,Seligson DB,Li A,Márquez DC,Wistuba II,Elshimali Y, et al.Aromatase expression predicts survival in women with early-stage non small cell lung cancer[].Cancer Research.2007
  • 9Travis WD,,Brambilla E,Muller-Hermelink HK,Harris CC.World Health Organization classification of tumours[].Pathology and Genetics of tumours of the lung pleura thymus and heart.2004
  • 10Niikawa H,Suzuki T,Miki Y,Suzuki S,Nagasaki S,Akahira J, et al.Intratumoral estrogens and estrogen receptors in human non small cell lung carcinoma[].Clinical Cancer Research.2008

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部